Introduction The regulatory framework governing Extrapolation of Indications in Biosimilar Approval is a well-established, science-driven approach that enables a biosimilar […]
PLGA Microsphere Formulation Development — Case Study Redesign :root{ –ink:#101d2b; –paper:#f6f5f1; –panel:#ffffff; –teal:#1b6e71; –teal-dim:#e4eeed; –amber:#b8802e; –amber-dim:#f4e9da; –slate:#57626e; –line:#e1ddd2; –line-dark:#28394a; }
Case Study: PLGA Microsphere Formulation Development for a 3-Month Depot Antipsychotic Read More »
Introduction: Bioequivalence study bioanalytical services are the laboratory backbone of every generic drug approval, formulation change, and lifecycle management submission
Introduction Nitrosamine Risk in Drug-Drug Combination Products has emerged as a significant toxicological challenge because combining multiple active pharmaceutical ingredients
Introduction Antisense Oligonucleotide-Peptide Conjugates have emerged as an advanced therapeutic platform designed to address the longstanding pharmacokinetic, biodistribution, and intracellular
Introduction: Nitrosamine leachables in blister packaging have become one of the most closely scrutinized contamination pathways in oral solid dosage
Introduction The structural characterization of biomolecular assemblies increasingly depends on Native Mass Spectrometry for Therapeutic Peptide Characterization, as it enables
Introduction Professional PLGA Microsphere Scale-Up Services provide the essential engineering, analytical, and manufacturing infrastructure needed to successfully transition complex poly(lactic-co-glycolic
PLGA Microsphere Scale-Up Services: From Lab Bench to Pilot and GMP Manufacturing Read More »
Introduction Nitrosamines from Excipients primarily arise when trace levels of nitrite impurities present in inactive formulation components react with susceptible
Introduction Protein Binding and Free Fraction Measurement in Bioanalysis is a fundamental analytical process used to determine the concentration of
